文献速递泌尿生殖腹部USCT

囊性肾肿块超声造影与增强CT的Bosniak分类临床评估

Clinical Evaluation of Cystic Renal Masses With Bosniak Classification by Contrast-Enhanced Ultrasound and Contrast-Enhanced Computer Tomography.
PubMed 文献 · J Ultrasound Med · 2023-09-21

本文回顾性分析了2013年1月至2022年7月49例连续患者的52个Bosniak II-IV级囊性肾肿块,所有患者同时接受超声造影(CEUS)与增强CT(CECT)检查,以病理诊断和病灶稳定性为参考标准,比较CEUS(EFSUMB 2020版)、CEUS(2019版)及CECT(2019版)的Bosniak分类诊断效能。结果显示三种方法的kappa值分别为0.696、0.735和0.696,CEUS(2019版)正确诊断22个恶性肿块,CEUS(EFSUMB 2020版)与CECT(2019版)各正确诊断21个恶性肿块、1个误诊。

要点

  • CEUS(EFSUMB 2020版)、CEUS(2019版)与CECT(2019版)Bosniak分类与参考标准的kappa值分别为0.696、0.735和0.696。
  • 在49个有病理结果的囊性肾肿块中,壁/分隔厚度≥4 mm、壁/分隔厚度、强化结节存在及直径与恶性相关,差异有统计学意义。
  • CEUS(2019版)正确诊断22个恶性肿块,CEUS(EFSUMB 2020版)和CECT(2019版)各正确诊断21个恶性肿块,1个肿块误诊。

核心结论

  • EFSUMB 2020版Bosniak分类在诊断囊性肾肿块方面可能和2019版CEUS及2019版CECT一样准确,CEUS在临床工作中显示出极好的安全性。

研究设计与样本

  • 回顾性研究,纳入2013年1月至2022年7月49例连续患者的52个Bosniak II-IV级囊性肾肿块,所有患者同时接受CEUS和CECT检查,以病理诊断和肿块稳定性(随访超过5年)为参考标准。

诊断标准与关键数值

  • CEUS(EFSUMB 2020版)将52个肿块分为8个II类、16个IIF类、15个III类、13个IV类;CEUS(2019版)分为10个II类、13个IIF类、16个III类、13个IV类;CECT(2019版)分为15个II类、9个IIF类、13个III类、15个IV类。与参考标准相比,CEUS(EFSUMB 2020版)、CEUS(2019版)、CECT(2019版)的kappa值分别为0.696、0.735、0.696。在49个有病理结果的肿块中,壁/分隔厚度≥4 mm、壁/分隔厚度、强化结节存在及直径对恶性有统计学意义。

临床应用与阅片要点

  • 作者认为EFSUMB 2020版Bosniak分类可能和2019版CEUS及2019版CECT一样准确,CEUS在临床工作中显示出极好的安全性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: The study aims to compare retrospectively three clinically applied methods for the diagnostic performance of cystic renal masses (CRMs) by contrast-enhanced ultrasound (CEUS) and contrast-enhanced computer tomography (CECT) with Bosniak classification system.

METHODS: A total of 52 cases of Bosniak II-IV CRMs in 49 consecutive patients were diagnosed from January 2013 to July 2022 and their data were analyzed. All patients had been subjected to CEUS and CECT simultaneously. Pathological diagnoses and masses stability were used as standard references to determine whether lesions were malignant or benign. Then 49 CRMs only with pathologic results were classified into group 1 and 2.

RESULTS: A total of 52 CRMs in 49 enrolled patients were classified into 8 category II, 16 category IIF, 15 category III, and 13 category IV by CEUS (EFSUMB 2020), 10 category II, 13 category IIF, 16 category III, and 13 category IV by CEUS (V2019), while 15 category II, 9 category IIF, 13 category III, and 15 category IV by CECT (V2019). Pathological results and masses stability longer than 5 years follow-up performed substantially for CEUS (EFSUMB 2020), CEUS (V2019), and CECT (V2019) (kappa values were 0.696, 0.735, and 0.696, respectively). Among 49 pathologic approving CRMs, wall/septation thickness ≥4 mm, wall/septation thickness, presence of enhancing nodule and the diameter were found to be statistically significant for malignancy. Twenty-two malignant masses were correctly diagnosed by CEUS (V2019), while 21 malignant masses were both correctly diagnosed by CEUS (EFSUMB 2020) and CECT (V2019), and 1 mass was misdiagnosed.

CONCLUSIONS: Bosniak classification of EFSUMB 2020 version might be as accurate as version 2019 CEUS and version 2019 CECT in diagnosing CRMs, and CEUS is found to have an excellent safety profile in dealing with clinical works.

来源:J Ultrasound Med,查看原文。版权归原作者所有。

引用

  1. Lan L, Yang Y, Xu ZQ, et al. Clinical Evaluation of Cystic Renal Masses With Bosniak Classification by Contrast-Enhanced Ultrasound and Contrast-Enhanced Computer Tomography. J Ultrasound Med. 2023. PMID: 37732901. doi:10.1002/jum.16324

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。